Syneron Bio
Irvine, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $100M
Overview
Develops energy-based medical aesthetic devices for professional and consumer markets.
DermatologyAesthetic Medicine
Technology Platform
Proprietary elōs technology that combines bipolar radiofrequency with optical energy (laser or IPL) for safe and effective aesthetic treatments.
Funding History
1Total raised:$100M
Series A$100M
Opportunities
Growth driven by increasing global demand for non-invasive aesthetic procedures and expansion into new geographic and demographic markets.
Risk Factors
Susceptible to rapid technological obsolescence, intense price competition, and regulatory changes across different international markets.
Competitive Landscape
A mature, competitive market with several large, well-capitalized players constantly innovating on device technology and expanding treatment indications.